<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941202-0-00037</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> 51. Section 35.980 is added to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.980  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for an authorized nuclear pharmacist.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The licensee shall require the authorized nuclear pharmacist to be a pharmacist who:  <!-- PJG 0012 frnewline --> (a) Has current board certification as a nuclear pharmacist by the Board of Pharmaceutical Specialties, or  <!-- PJG 0012 frnewline --> (b)(1) Has completed 700 hours in a structured educational program consisting of both:  <!-- PJG 0012 frnewline --> (i) Didactic training in the following areas:  <!-- PJG 0012 frnewline --> (A) Radiation physics and instrumentation;  <!-- PJG 0012 frnewline --> (B) Radiation protection;  <!-- PJG 0012 frnewline --> (C) Mathematics pertaining to the use and measurement of radioactivity; (D) Chemistry of byproduct material for medical use; and  <!-- PJG 0012 frnewline --> (E) Radiation biology; and  <!-- PJG 0012 frnewline --> (ii) Supervised experience in a nuclear pharmacy involving the following:  <!-- PJG 0012 frnewline --> (A) Shipping, receiving, and performing related radiation surveys;  <!-- PJG 0012 frnewline --> (B) Using and performing checks for proper operation of dose calibrators, survey meters, and, if appropriate, instruments used to measure alpha- or beta-emitting radionuclides;  <!-- PJG 0012 frnewline --> (C) Calculating, assaying, and safely preparing dosages for patients or human research subjects;  <!-- PJG 0012 frnewline --> (D) Using administrative controls to avoid mistakes in the administration of byproduct material;  <!-- PJG 0012 frnewline --> (E) Using procedures to prevent or minimize contamination and using proper decontamination procedures; and  <!-- PJG 0012 frnewline --> (2) Has obtained written certification, signed by a preceptor authorized nuclear pharmacist, that the above training has been satisfactorily completed and that the individual has achieved a level of competency sufficient to independently operate a nuclear pharmacy.  <!-- PJG 0012 frnewline --> 52. Section 35.981 is added to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.981  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for experienced nuclear pharmacists.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> A licensee may apply for and must receive a license amendment identifying an experienced nuclear pharmacist as an authorized nuclear pharmacist before it allows this individual to work as an authorized nuclear pharmacist. A pharmacist who has completed a structured educational program as specified in &sect;35.980(b)(1) before (the date of publication in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) and who is working in a nuclear pharmacy would qualify as an experienced nuclear pharmacist. An experienced nuclear pharmacist need not comply with the requirements on preceptor statement (&sect;35.980(b)(2)) and recentness of training (&sect;35.972) to qualify as an authorized nuclear pharmacist.  <!-- PJG 0012 frnewline --> 53. In &sect;35.991, paragraph (b) is revised to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.991  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Criminal penalties.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (b) The regulations in Part 35 that are not issued under subsections 161b, 161i, or 161o for the purposes of section 223 are as follows: &sect;&sect;35.1, 35.2, 35.7, 35.8, 35.12, 35.15, 35.18, 35.19, 35.57, 35.100, 35.600, 35.901, 35.970, 35.971, 35.990, 35.991, and 35.999. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated at Rockville, Maryland, this 25th day of November, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> For the Nuclear Regulatory Commission.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> John C. Hoyle  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Secretary of the Commission.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;29525 Filed 12&hyph;1&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 7590&hyph;01&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            